SANJANA PATEL: Open Payments
NPI 1407560121 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 73 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $602 · 2025 $1,510
Food & beverage: $1,431Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $433 |
| ABBVIE INC. | 17 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $224 |
| Lilly USA, LLC | 9 | $204 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| Celltrion USA Inc. | 4 | $72 |
| PFIZER INC. | 4 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Organon LLC | 3 | $44 |
| Ardelyx, Inc. | 2 | $41 |
Products named: TREMFYA, OMVOH, RINVOQ, ENTYVIO, DUPIXENT, VEGZELMA, XIFAXAN, XELJANZ.
Industry payments across NJ — which companies pay providers there.
